311P Exploring circulating MDSC role in immune-related adverse events (irAEs) in early triple-negative breast cancer (eTNBC): A preliminary analysis from the IRIS study. - Taglialatela, I.; Negrini, L.; Martini, V.; Conte, B.; Landolfo, T.L.; Ruffilli, B.; Isingrini, G.; D'Avanzo, F.; Rossi, V.; Nardin, S.; Branni, C.; Gennari, J.; et al. (Annals of Oncology, 2025)